Date(s)

6 Jul 2016

Location

Durban, South Africa

Organizer

Global HIV Clinical Forum 2016

Related Enduring Materials

Enduring Materials

Basic Science of Integrase Inhibitors

Mark Wainberg, MD

McGill University, Canada

Slideset

Video

Resistance Characteristics of Integrase inhibitors

Charles Boucher, MD, PhD

Erasmus Medical Center, The Netherlands

Slideset

Video

Clinical Case Discussion 1

Pedro Cahn, MD, PhD

Fundación Huésped Buenos Aires, Argentina

Slideset

Video

Clinical Case Discussion 2

Loice Achieng Ombajo, MD

University of Nairobi , Kenya

Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

Slideset

Video

Optimizing HIV Therapy in Resource Limited Settings

François Venter, MD, FCP, PhD

Ezintsha, University of the Witwatersrand, South Africa

Slideset

Video

Only the Best in Botswana - Optimizing the ART Response

Ava Avalos, MD

Careena Medical Center , Botswana

Slideset

Video

Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection

Juan Ambrosioni

Hospital Clinic-IDIBAPS , Spain

Slideset

Dolutegravir plus two nucleoside reverse transcriptase inhibitors versus efavirenz plus two nucleoside reverse transcriptase inhibitors as initial antiretroviral therapy for people with HIV: a systematic review

George Rutherford, MD, AM

University of California, San Francisco , USA

Slideset

Response to Raltegravir based third-line antiretroviral therapy among Ugandan children: A Case series from an urban HIV clinic

Victor Musiime, MBChB, MMed, PhD

Joint Clinical Research Centre/Makerere University, Uganda

Slideset

Cross-resistance to integrase strand transfer inhibitors (INSTIs) in 23 multiexperienced Mexican patients failing to raltegravir

Aurelio Orta-Reséndiz, MD, MSc

Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" , Mexico

Slideset

HIV Therapy in Populations with Unique Challenges – Pediatrics

Victor Musiime, MBChB, MMed, PhD

Joint Clinical Research Centre/Makerere University, Uganda

Slideset

Video

Pharmacological Considerations & Clinical Case Discussion

Anna Maria Geretti, MD, PhD, FRCPath

University of Rome, Italy / King's College London, United Kingdom

Slideset

Video

Future Challenges of HIV treatment

Stefano Vella, MD

Istituto Superiore di Sanità , Italy

Slideset

Video

Overview

The Global HIV Clinical Forum was held on 16 July, 2016 in Durban (SA), preceding the 21st International AIDS Conference.

The meeting was an incredible success with almost 200 unique attendees visiting the meeting.

The Global HIV Clinical Forum focused entirely on Integrase Inhibitors as Integrase Inhibitors are rapidly gaining a central role in the routine care of HIV infected individuals. The HIV Clinical Forum meetings aim at enhancing the clinical skills and research capabilities of HIV healthcare professionals in regard to this unique class of antiretroviral drugs.

On behalf of the Global HIV Clinical Forum meeting chairs, we would like to thank our sponsors, our endorsers and of course all of our participants in making this meeting into a huge success!

General Information

Meeting Objectives

With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients

- Create a platform for interactive information exchange on novel treatment options

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV

Learning Objectives

After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies

- Describe the pros and cons of novel treatment strategies

- Understand how to integrate novel treatment strategies into routine patient care

- Be knowledgeable of the clinical data supporting long-acting injectable regimens

- Identify patients who might best benefit from long acting injectable regimens

- Know how best to integrate injectable drugs in to routine clinical care

- Improve their skills in defining and identifying complex HIV patients

- Stay informed on new drug options for complex patients

- Understand how best to use new treatment options in complex HIV patients

Practical Information

CME Accreditation

The Global HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Certificate of Attendance

A certificate of attendance was sent to individuals that successfully completed the program and post-meeting survey.

Disclaimer

This forum is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this forum. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the forum.

Support